Ryan Specialty (NYSE:RYAN – Get Free Report) posted its earnings results on Thursday. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.05), FiscalAI reports. Ryan Specialty had a net margin of 7.02% and a return on equity of 47.38%. The company had revenue of $751.21 million for the quarter, compared to the consensus estimate of $777.43 million. During the same quarter last year, the business earned $0.45 earnings per share. Ryan Specialty’s quarterly revenue was up 13.2% on a year-over-year basis.
Here are the key takeaways from Ryan Specialty’s conference call:
- Company delivered resilient growth with its 15th consecutive year of double‑digit organic growth (10.1% for FY2025) and total revenue above $3 billion, underscoring platform strength despite industry headwinds.
- Property pricing deteriorated sharply in Q4 — notably 25%–35% rate declines on some large accounts — and management expects continued property pressure into 2026, a clear near‑term drag on revenue and margins.
- Delegated authority and underwriting businesses have rapidly expanded (delegated revenue doubled to $1.4 billion, now ~47% of total; platform manages north of $10 billion of premium and 300+ products), providing diversification and new growth channels.
- Management launched Project Empower, a three‑year restructuring with an anticipated cumulative special charge of ~$160 million through 2028 and expected annual run‑rate savings of ~$80 million by 2029, trading near‑term costs for multi‑year efficiency gains and AI enablement.
- Board approved a $300 million share repurchase program and an 8% dividend increase, signaling confidence in the company’s outlook while keeping M&A as the top allocation priority.
Ryan Specialty Stock Performance
Shares of RYAN opened at $38.64 on Friday. The stock has a 50 day moving average of $50.16 and a 200 day moving average of $54.02. The company has a market capitalization of $10.19 billion, a price-to-earnings ratio of 91.99, a PEG ratio of 1.12 and a beta of 0.62. Ryan Specialty has a 12 month low of $37.29 and a 12 month high of $77.16. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 2.72.
Ryan Specialty Increases Dividend
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on the company. Jefferies Financial Group started coverage on Ryan Specialty in a research note on Monday, December 1st. They issued a “hold” rating and a $64.00 price objective on the stock. JPMorgan Chase & Co. reduced their price target on Ryan Specialty from $63.00 to $56.00 and set an “underweight” rating on the stock in a research report on Wednesday, January 7th. BMO Capital Markets decreased their target price on Ryan Specialty from $70.00 to $66.00 and set an “outperform” rating for the company in a research note on Monday, November 3rd. Cantor Fitzgerald lowered their price target on shares of Ryan Specialty from $63.00 to $52.00 and set a “neutral” rating on the stock in a research note on Wednesday, January 14th. Finally, Mizuho set a $53.00 price objective on Ryan Specialty in a research note on Friday. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $61.25.
Check Out Our Latest Stock Analysis on RYAN
Insider Activity
In other news, CEO Timothy William Turner sold 129,570 shares of Ryan Specialty stock in a transaction on Friday, December 12th. The stock was sold at an average price of $53.61, for a total transaction of $6,946,247.70. Following the sale, the chief executive officer directly owned 12,553 shares in the company, valued at $672,966.33. The trade was a 91.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 52.21% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Ryan Specialty
Large investors have recently modified their holdings of the stock. Morgan Stanley lifted its stake in Ryan Specialty by 3.4% in the fourth quarter. Morgan Stanley now owns 2,840,310 shares of the company’s stock valued at $146,645,000 after purchasing an additional 92,593 shares during the last quarter. Viking Global Investors LP grew its stake in shares of Ryan Specialty by 37.0% during the 3rd quarter. Viking Global Investors LP now owns 1,934,957 shares of the company’s stock worth $109,054,000 after acquiring an additional 522,190 shares during the period. Polar Capital Holdings Plc lifted its holdings in Ryan Specialty by 11.4% during the 3rd quarter. Polar Capital Holdings Plc now owns 1,687,500 shares of the company’s stock worth $95,108,000 after purchasing an additional 172,500 shares in the last quarter. Bank of America Corp DE lifted its stake in shares of Ryan Specialty by 47.1% in the 2nd quarter. Bank of America Corp DE now owns 1,171,141 shares of the company’s stock valued at $79,626,000 after acquiring an additional 375,191 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Ryan Specialty by 1.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,072,703 shares of the company’s stock worth $55,384,000 after buying an additional 14,845 shares during the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.
Ryan Specialty News Roundup
Here are the key news stories impacting Ryan Specialty this week:
- Positive Sentiment: Quarterly dividend raised to $0.13 (8.3% increase); the payout yields ~1.2% and signals management support for the stock. (No article link)
- Positive Sentiment: Management expects about $80M of annual savings from the Empower restructuring, which should help offset cost pressures over time. Read More.
- Neutral Sentiment: Some sell-side firms cut price targets (Keefe, Bruyette & Woods: $65 → $55; Wells Fargo: $63 → $56) but kept positive ratings (Outperform / Overweight), leaving meaningful upside from current levels despite reduced targets. Read More. • Read More.
- Neutral Sentiment: Revenue grew 13.2% YoY to $751.2M, but organic growth slowed to 6.6% — mixed top-line trend that shows scale but weaker underlying growth. Read More.
- Neutral Sentiment: Full Q4 earnings call transcript and several analyst write-ups are available for detail on guidance, segment performance and reserve/investment commentary. Useful for investors deciding whether the sell-off creates a buying opportunity. Read More.
- Negative Sentiment: Q4 missed Street expectations: EPS $0.45 vs. $0.50 consensus and revenue $751.2M vs. ~$777M expected; net income declined and management highlighted slower organic growth — the primary driver of the stock decline. Read More.
- Negative Sentiment: Margins came under pressure as the company “absorbs” investment costs and faces property-related pressures; analysts and trade press flagged margin compression as a material near-term risk. Read More.
- Negative Sentiment: Sell-side and media coverage highlight a “slow sales growth” outlook and the stock’s sharp intraday move, with elevated trading volume as investors reposition. That combination is intensifying the downward pressure. Read More. • Read More.
Ryan Specialty Company Profile
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
Recommended Stories
- Five stocks we like better than Ryan Specialty
- ALERT: Drop these 5 stocks before January 2026!
- Think You Missed Silver? You’re Wrong. Here’s Why.
- Your Bank Account Is No Longer Safe
- Will Social Security checks vanish by 2027?
- Is Trump Done? Shocking leak…
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
